메뉴 건너뛰기




Volumn 15, Issue 6, 2004, Pages 575-579

Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CATHFLO ACTIVASE; PLACEBO; PLASMINOGEN ACTIVATOR; RECOMBINANT UROKINASE; UNCLASSIFIED DRUG; UROKINASE; UROKINASE ALPHA;

EID: 2942556571     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000124950.24134.19     Document Type: Article
Times cited : (13)

References (8)
  • 1
    • 0016257497 scopus 로고
    • The Role of catheter composition in the development of thrombophlebitis
    • Welch GW, McKeel DW Jr, Silverstein B, et al. The Role of catheter composition in the development of thrombophlebitis. Surg Gynecol Obstet 1974; 138:421-424.
    • (1974) Surg Gynecol Obstet , vol.138 , pp. 421-424
    • Welch, G.W.1    McKeel Jr., D.W.2    Silverstein, B.3
  • 4
    • 0019036430 scopus 로고
    • Therapy for thrombotic occlusion of long term intravenous alimentation catheters
    • Glynn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long term intravenous alimentation catheters. JPEN J Parenter Enteral Nutr 1980; 4:387-390.
    • (1980) JPEN J Parenter Enteral Nutr , vol.4 , pp. 387-390
    • Glynn, M.F.1    Langer, B.2    Jeejeebhoy, K.N.3
  • 6
    • 0025209871 scopus 로고
    • Urokinase administration in pediatric patients with occluded central venous catheters
    • Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intravenous Nursing 1980; 13:100-102.
    • (1980) J Intravenous Nursing , vol.13 , pp. 100-102
    • Wachs, T.1
  • 7
    • 0034877251 scopus 로고    scopus 로고
    • Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial-The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial
    • Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER, COOL Investigators. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial. J Vasc Interv Radiol 2001; 12:951-955.
    • (2001) J Vasc Interv Radiol , vol.12 , pp. 951-955
    • Ponec, D.1    Irwin, D.2    Haire, W.D.3    Hill, P.A.4    Li, X.5    McCluskey, E.R.6
  • 8
    • 0036137741 scopus 로고    scopus 로고
    • The safety and efficacy of alteplase (t-PA) for restoring function in occluded central venous catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial
    • Deitcher SR, Fesen MR, Kiproff PM, et al. The safety and efficacy of alteplase (t-PA) for restoring function in occluded central venous catheters: results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial. J Clin Oncol 2002; 20:317-324.
    • (2002) J Clin Oncol , vol.20 , pp. 317-324
    • Deitcher, S.R.1    Fesen, M.R.2    Kiproff, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.